Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
Researchers across Columbia University—including psychiatrists, data scientists, social workers, and engineers—are combining their efforts to address the opioid and substance use crisis.
About 13% of pregnant women who are depressed use cannabis, while only 4% of pregnant women without depression do, according to a new study from Columbia University Mailman School of Public Health.
Non-medical cannabis use—including frequent or problematic use—is more common in adults with pain than in those without pain, a new study from Columbia University has found.
Prenatal exposure to PDBEs—compounds previously used as flame retardants—may increase the risk of reading problems in children, a new study from Columbia University has found.
The fall/winter 2019 issue of Columbia Medicine magazine explores the epidemic of suicide, which is the 10th leading cause of death in the United States.
People with opioid addiction face a high risk of overdose after ending treatment with buprenorphine, even when treated for 18 months, a new study from Columbia University has found.
A new study has identified markers of maternal stress—both physical and psychological—that may influence a baby’s sex and the likelihood of preterm birth.